Advertisement
Research Article

Changes in JC Virus-Specific T Cell Responses during Natalizumab Treatment and in Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

  • Molly R. Perkins,

    Affiliations: Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America, MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom

    X
  • Caroline Ryschkewitsch,

    Affiliation: Laboratory of Molecular Medicine and Neuroscience, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Julia C. Liebner,

    Affiliation: Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Maria Chiara G. Monaco,

    Affiliation: Laboratory of Molecular Medicine and Neuroscience, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Danielle Himelfarb,

    Affiliation: Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Sara Ireland,

    Affiliation: Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

    X
  • Annelys Roque,

    Affiliation: Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Heather L. Edward,

    Affiliation: Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Peter N. Jensen,

    Affiliation: Laboratory of Molecular Medicine and Neuroscience, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Gina Remington,

    Affiliation: Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

    X
  • Thomas Abraham,

    Affiliation: Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

    X
  • Jaspreet Abraham,

    Affiliation: Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

    X
  • Benjamin Greenberg,

    Affiliation: Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

    X
  • Charles Kaufman,

    Affiliation: Louisiana Neurologic Consultants. Baton Rouge, Louisiana, United States of America

    X
  • Chris LaGanke,

    Affiliation: North Central Neurology, Cullman, Alabama, United States of America

    X
  • Nancy L. Monson,

    Affiliation: Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

    X
  • Xiaoning Xu,

    Affiliation: MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom

    X
  • Elliot Frohman,

    Affiliation: Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

    X
  • Eugene O. Major mail,

    majorg@ninds.nih.gov (EOM); ddouek@mail.nih.gov (DCD)

    Affiliation: Laboratory of Molecular Medicine and Neuroscience, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Daniel C. Douek mail

    majorg@ninds.nih.gov (EOM); ddouek@mail.nih.gov (DCD)

    Affiliation: Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Published: November 08, 2012
  • DOI: 10.1371/journal.ppat.1003014

Reader Comments (0)

Post a new comment on this article